Shaun Rodriguez
Directeur/Bestuurslid bij Multiply Labs, Inc.
Profiel
Shaun Rodriguez has worked as a Director at Multiply Labs, Inc. and Exai Bio, Inc.
Actieve functies van Shaun Rodriguez
| Bedrijven | Functie | Begin |
|---|---|---|
Multiply Labs, Inc.
 Multiply Labs, Inc. Pharmaceuticals: MajorHealth Technology Multiply Labs, Inc. provides individuals to customize their intake of supplements to optimize their day. It offers vitamins, omega 3, iron, folic acid and caffeine medicines. The company was founded by Alice Melocchi, Tiffany Kuo, Fred Parietti and Joe Wilson and is headquartered in San Francisco, CA. | Directeur/Bestuurslid | - |
Exai Bio, Inc.
 Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Multiply Labs, Inc.
Multiply Labs, Inc. Pharmaceuticals: MajorHealth Technology Multiply Labs, Inc. provides individuals to customize their intake of supplements to optimize their day. It offers vitamins, omega 3, iron, folic acid and caffeine medicines. The company was founded by Alice Melocchi, Tiffany Kuo, Fred Parietti and Joe Wilson and is headquartered in San Francisco, CA. | Health Technology |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | Technology Services |